Celltrion chairman\
Scope
Date
~
-
Bio & Pharma
Celltrion to release Stelara biosimilar in US from March 2025
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it has completed a patent agreement with Johnson & Johnson, the m...
Aug 25, 2023 (Gmt+09:00)
-
Electronics
LG Display boosts ties with Mercedes-Benz in vehicle screens
South Korea's LG Display Co. has reinforced its auto display cooperation with German automotive giant Mercedes-Benz, raising prospects that the form...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion considers listing holding firm after merger of 3 units
South Korean drug giant Celltrion Group will consider listing its holding company if necessary, after it completes the merger of three affiliates &n...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on prescription of 10 private US insurers
South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...
Aug 23, 2023 (Gmt+09:00)
-
Retail
Lotte’s intra-group merger, business integration fare well
Lotte Mart and Lotte Super are leading Lotte Group’s efforts to streamline the overlapping businesses of its units. Their second-quarter resul...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets OK partial approval for phase 3 of biosimilar in Europe
South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to merge with global sales affiliate by end-2023
South Korean pharmaceutical giant Celltrion Group has begun procedures to merge biopharmaceuticals developer and producer Celltrion Inc. with global...
Aug 17, 2023 (Gmt+09:00)
-
Business & Politics
Korea’s Big Four conglomerates likely to regain FKI membership
South Korea’s four largest business conglomerates – Samsung, Hyundai Motor, SK and LG – will likely return as members of the count...
Aug 09, 2023 (Gmt+09:00)
-
Airlines
Hanjin KAL secures liquidity to keep chairman's control of firm
Hanjin KAL Corp., the holding firm of South Korean flag carrier Korean Air Lines Co., is actively raising money via bond issuances and sale of prope...
Aug 08, 2023 (Gmt+09:00)
-
Fiber & Textile
The North Face supplier Youngone hints at succession plan
Youngone Corp., a South Korean outdoor clothing maker to global brands like The North Face and Patagonia, has given a clearer signal that Chairman...
Aug 07, 2023 (Gmt+09:00)
-
Leadership & Management
Cosmetics giant Amorepacific hints at succession plan change
South Korean cosmetics powerhouse Amorepacific Group Inc. is giving signs of changing its succession plans as Suh Min-jung, Chairman Suh Kyung-bae&r...
Jul 31, 2023 (Gmt+09:00)
-
Leadership & Management
S.Korea's HD Hyundai chairman: We can’t rely on bad profits
Kwon Oh-gap, chairman and co-CEO of South Korea's HD Hyundai Co., has ordered his company not to rely on “bad profits” gained from tempo...
Jul 31, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
First S.Korean elected chairman of global shipbuilding committee
HD Korea Shipbuilding & Offshore Engineering (HD KSOE) announced on Tuesday that their technical advisor, Shin Jong Gye, has been elected as the...
Jul 25, 2023 (Gmt+09:00)
-
Korean chipmakers
SK Group chair sees semiconductor rebound in 6 mths to 1 yr
The semiconductor industry may be at the bottom of its cycle and is likely to turn around in six months to one year, in tandem with an expected econ...
Jul 13, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor chairman visits Intel, seeking stable supply of chips
Hyundai Motor Group Chairman Chung Euisun toured Intel Corp.’s Leixlip Campus in County Kildare, Ireland last week to check out the latest tec...
Jul 10, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics, Celltrion pledge major CO2 cuts
South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...
Jul 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Humira biosimilar Yuflyma in US
South Korean biopharmaceutical company Celltrion Healthcare on Monday said it launched the day before on the US market Yuflyma, a biosimilar of the ...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Robotics
Doosan vice chairman visits robotics trade show Automatica
South Korea’s Doosan Group Vice Chairman Park Ji-won visited Automatica 2023 on Wednesday, a leading trade fair for smart automation held in M...
Jun 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion puts Takeda’s assets up for sale after 3 years
South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...
Jun 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Airlines
Korean Air says it can conclude Asiana takeover via big concessions
The head of Korean Air Lines Co. has expressed confidence over the airliner's proposed acquisition of Asiana Airlines, saying, "We will make it happ...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
-
Corporate strategy
POSCO to comply with IRA rules to access battery tax breaks: chairman
NEW YORK – POSCO Group, which owns South Korea’s largest steelmaker, has been striving to transform into a low-carbon conglomerate by sh...
Jun 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Steel
POSCO, JSW discuss eco-friendly reduction steel production
Chairman of POSCO Group Choi Jeong-woo met with Sajjan Jindal, Chairman of JSW Steel, India's largest steel conglomerate, to discuss collaboration...
May 23, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand